4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000005
Director sold 1,300 shares at $604.64 ($786,032)
- Director acquired 1,300 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CAUSEY CHRISTOPHER · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,300 | $119.76 | $155,688 | 5,490 | D |
| 2026-03-30 | Sale : show line 2 in the form 10b5-1 | −1,300 | $604.64 | $786,032 | 4,190 | D |
| Open-market sales · 1,300 sh · avg $604.64 · $786,032 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −1,300 | 5,000 | D |
Loading xslF345X06/primarydocument.xml…